Impaired Coronary Microcirculation and Myocardial Systolic Function: A Narrative Review on Non-Invasive Assessment in Cardiovascular Diseases
Related Experiment Video
Updated: Jul 3, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Evangelos Tatsis1, Constantinos Papadopoulos1, Dimitrios Oikonomidis1
1Second Department of Cardiology, "Korgialenio Mpenakio"-Hellenic Red Cross Hospital, 11526 Athens, Greece.
Insights
Coronary microvascular dysfunction (CMD) impairs blood flow and cardiac outcomes. This review explores non-invasive imaging techniques for CMD and its link to systolic function, crucial for developing new therapies.
Area of Science:
- Cardiology
- Medical Imaging
- Physiology
Background:
- Coronary microvascular dysfunction (CMD) is a condition of reduced coronary blood flow linked to adverse cardiac events.
- Evidence suggests coronary microcirculation impairment occurs in various cardiovascular pathologies.
- Non-invasive assessment of CMD is challenging, impacting clinical management.
Purpose of the Study:
- To review current evidence on non-invasive imaging modalities for assessing CMD.
- To examine the association between CMD indices and systolic myocardial function.
- To highlight CMD as a potential therapeutic target in cardiovascular diseases.
Main Methods:
- Review of current literature on CMD imaging techniques.
- Analysis of studies correlating CMD indices with systolic function markers (e.g., LVEF, GLS, myocardial work).
- Discussion of limitations and diagnostic utility of various imaging modalities (PET, CT, CMR, MCE, TTE).
Main Results:
- Several non-invasive imaging modalities (PET, CT, CMR, MCE, TTE) can quantify coronary flow reserve (CFR) and myocardial blood flow (MBF).
- Each imaging modality has limitations regarding availability, standardization, and diagnostic utility.
- Growing evidence links CMD indices with systolic function markers in cardiovascular diseases.
Conclusions:
- Understanding the impact of CMD on myocardial function is vital.
- Coronary microcirculation impairment is a key pathway in cardiovascular disease.
- CMD assessment and its relationship with systolic function may guide future therapeutic strategies.
Abstract:
Coronary microvascular dysfunction (CMD) is presently recognized as a condition characterized by a reduction in coronary blood flow. CMD is associated with poor cardiac outcomes, and mounting evidence suggests that coronary microcirculation may be impaired in various cardiology pathologies. Non-invasive assessment of CMD remains challenging, and several imaging modalities-positron emission tomography (PET), computed tomography (CT), cardiac magnetic resonance (CMR), myocardial contrast echocardiography (MCE), and transthoracic Doppler echocardiography (TTE)-are proven to quantify coronary flow reserve (CFR) and myocardial blood flow (MBF), both valuable markers of CMD. However, each modality is limited by availability, standardization, and diagnostic utility. Furthermore, a growing number of studies have attempted to correlate CMD indices with systolic myocardial function markers, such as left ventricular ejection fraction, global longitudinal strain, and myocardial work indices. This review refers to the current evidence on CMD imaging and examines the association between CMD indices and systolic function in cardiovascular diseases. Understanding the impact of CMD on myocardial function is essential, as it highlights the coronary microcirculation impairment pathway as a potential target for therapeutic strategies.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies